BR112017009302A2 - uso de d-ribose para aperfeiçoar adaptação a tensão física - Google Patents

uso de d-ribose para aperfeiçoar adaptação a tensão física

Info

Publication number
BR112017009302A2
BR112017009302A2 BR112017009302A BR112017009302A BR112017009302A2 BR 112017009302 A2 BR112017009302 A2 BR 112017009302A2 BR 112017009302 A BR112017009302 A BR 112017009302A BR 112017009302 A BR112017009302 A BR 112017009302A BR 112017009302 A2 BR112017009302 A2 BR 112017009302A2
Authority
BR
Brazil
Prior art keywords
ribose
improve adaptation
physical tension
adaptation
tension
Prior art date
Application number
BR112017009302A
Other languages
English (en)
Inventor
Xue Yongquan
Original Assignee
Bioenergy Life Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioenergy Life Science Inc filed Critical Bioenergy Life Science Inc
Publication of BR112017009302A2 publication Critical patent/BR112017009302A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/33—High-energy foods and drinks, sports drinks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Abstract

a presente invenção refere-se a métodos de aperfeiçoamento de adaptação a tensão física através de administração de d-ribose e mé-todos de administração de d-ribose para aperfeiçoamento de adaptação a exercício físico.
BR112017009302A 2014-11-03 2015-11-03 uso de d-ribose para aperfeiçoar adaptação a tensão física BR112017009302A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462074611P 2014-11-03 2014-11-03
PCT/US2015/058902 WO2016073532A1 (en) 2014-11-03 2015-11-03 Use of d-ribose to enhance adaptation to physical stress

Publications (1)

Publication Number Publication Date
BR112017009302A2 true BR112017009302A2 (pt) 2017-12-19

Family

ID=55909723

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017009302A BR112017009302A2 (pt) 2014-11-03 2015-11-03 uso de d-ribose para aperfeiçoar adaptação a tensão física

Country Status (11)

Country Link
US (2) US20170339984A1 (pt)
EP (1) EP3215162A4 (pt)
JP (3) JP2017537079A (pt)
KR (1) KR20170082568A (pt)
CN (2) CN115708831A (pt)
AU (1) AU2015343221B2 (pt)
BR (1) BR112017009302A2 (pt)
CA (1) CA2966628C (pt)
HK (1) HK1243944A1 (pt)
RU (1) RU2746128C2 (pt)
WO (1) WO2016073532A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015343221B2 (en) * 2014-11-03 2021-04-08 Bioenergy Life Science, Inc. Use of D-ribose to enhance adaptation to physical stress

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715340D0 (en) * 1997-07-22 1997-09-24 Cerestar Holding Bv Beverages for enhanced physical performance
CN101264093B (zh) * 1998-06-19 2014-01-01 生物能量生命科学公司 用于增加体内能量的组合物
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
RU2169568C2 (ru) * 1998-07-14 2001-06-27 Омская государственная медицинская академия Средство для коррекции энергетического обмена
US6534480B2 (en) * 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
GB2353217B (en) * 1999-10-27 2001-07-18 Bioenergy Inc Use of ribose to treat fibromyalgia
US20030212006A1 (en) * 2002-05-13 2003-11-13 Seifert John G. Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
EP2323668A1 (en) * 2008-08-20 2011-05-25 Bioenergy Inc. Use of d-ribose for fatigued subjects
AU2015343221B2 (en) * 2014-11-03 2021-04-08 Bioenergy Life Science, Inc. Use of D-ribose to enhance adaptation to physical stress

Also Published As

Publication number Publication date
JP2021001224A (ja) 2021-01-07
CN115708831A (zh) 2023-02-24
RU2017119010A (ru) 2018-12-06
EP3215162A4 (en) 2018-06-27
JP2017537079A (ja) 2017-12-14
AU2015343221A1 (en) 2017-05-25
AU2015343221B2 (en) 2021-04-08
RU2017119010A3 (pt) 2019-06-10
JP2022190163A (ja) 2022-12-22
KR20170082568A (ko) 2017-07-14
EP3215162A1 (en) 2017-09-13
WO2016073532A1 (en) 2016-05-12
CA2966628C (en) 2023-08-29
US20210227854A1 (en) 2021-07-29
HK1243944A1 (zh) 2018-07-27
CN107249597A (zh) 2017-10-13
CA2966628A1 (en) 2016-05-12
RU2746128C2 (ru) 2021-04-07
US20170339984A1 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
CL2016002455A1 (es) Anticuerpos multiespecíficos.
BR112016022658A2 (pt) anticorpos anti-ox40 e métodos de uso
DK3129063T3 (da) Anti-her3-antistof-lægemiddelkonjugat
DK3226960T3 (da) Oral muskeltræning
DK3245744T3 (da) Kodebogssubsætrestriktionssignalering
BR112017008659A2 (pt) ?métodos e compostos de agonista de gip?
DK3590962T3 (da) Enkeltdomæneantistoffer rettet mod intracellulære antigener
DK3466976T3 (da) Anti-her2-antistof-lægemiddelkonjugat
BR112017009297A2 (pt) anticorpos antifator de complemento c1q humanizados e usos dos mesmos
BR112017000456A2 (pt) composições antivirais tópicas e métodos de uso das mesmas
ECSP17015977A (es) Terapia de combinacion
BR112016017112A2 (pt) Composições de apilimod e métodos de uso das mesmas
BR112019010131A2 (pt) entrega transdérmica de agentes grandes
BR112017018834A2 (pt) variantes de protoxina-ii e métodos de uso
DK3145984T3 (da) Terapeutiske konjugater med sulfaterede dendrimerer til intracellulær målretning
BR112018012313A2 (pt) composições que compreendem 15-hepe e métodos para uso das mesmas
DK3302649T3 (da) Lægemiddeladministrationsanordning med lydindikatorfjeder
BR112016007062A2 (pt) variantes de protoxina-ii e métodos de uso
BR112017020896A2 (pt) variantes de protoxina-ii e métodos de uso
BR112018002382A8 (pt) Novos anticorpos anti-gvpi humano e usos dos mesmos
DK3538542T3 (da) Cykliske peptidmultimerer målrettet alfa-4beta-7-integrin
DK3296485T3 (da) Ståldrager
BR112017013286A2 (pt) composto de isoxazolina, e, uso de um composto de isoxazolina.
BR112017009302A2 (pt) uso de d-ribose para aperfeiçoar adaptação a tensão física
BR112017005376A2 (pt) inibidores de mao-b e reabilitação.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]